<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Peter Blanckaert</style></author><author><style face="normal" font="default" size="100%">Annelies Cannaert</style></author><author><style face="normal" font="default" size="100%">Katleen Van Uytfanghe</style></author><author><style face="normal" font="default" size="100%">Fabian Hulpia</style></author><author><style face="normal" font="default" size="100%">Eric Deconinck</style></author><author><style face="normal" font="default" size="100%">Van Calenbergh, Serge</style></author><author><style face="normal" font="default" size="100%">Stove, Christophe</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Report on a novel emerging class of highly potent benzimidazole NPS opioids: chemical and in vitro functional characterization of isotonitazene</style></title><secondary-title><style face="normal" font="default" size="100%">Drug Testing and Analysis</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">19 nov 2019</style></date></pub-dates></dates><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>